Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05450965
Title Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Taofeek Owonikoko
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.